Related Experiment Video
Updated: Feb 8, 2026

Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse
Published on: July 25, 2025
Patient Outcomes Following Micropulse Transscleral Cyclophotocoagulation: Intermediate-term Results
Aleksandr Yelenskiy1, Thomas B Gillette1, Analisa Arosemena2
1Department of Ophthalmology, Tulane University School of Medicine, Tulane University, New Orleans, LA.
Micropulse transscleral cyclophotocoagulation (MPTSCPC) is a safe and effective treatment for uncontrolled glaucoma, significantly reducing intraocular pressure and medication needs. This study shows a 71% success rate, with 90% of patients avoiding repeat procedures at 12 months.
Area of Science:
- Ophthalmology
- Glaucoma Treatment
- Surgical Innovation
Background:
- Glaucoma management often requires effective and safe interventions to control intraocular pressure (IOP).
- Micropulse transscleral cyclophotocoagulation (MPTSCPC) offers a less invasive approach compared to traditional cyclodestructive procedures.
- Evaluating the long-term safety and efficacy of MPTSCPC is crucial for its clinical adoption.
Purpose of the Study:
- To assess the safety and efficacy outcomes of the micropulse transscleral cyclophotocoagulation (MPTSCPC) procedure.
- To evaluate the impact of MPTSCPC on intraocular pressure, visual acuity, and medication requirements in patients with uncontrolled glaucoma.
- To identify predictors of success for MPTSCPC in a diverse glaucoma population.
Main Methods:
- A longitudinal retrospective cohort study involving 197 eyes from 161 patients across 5 centers.
- Patients with various types of glaucoma underwent MPTSCPC using the P3 probe between July 2015 and May 2017.
- Data collected included preoperative characteristics, surgical details, and postoperative outcomes, analyzed using logistic regression and Kaplan-Meier survival analysis.
Main Results:
- The overall success rate for MPTSCPC was 71%, with a significant reduction in mean intraocular pressure from 22±9 mmHg to 16±6 mmHg (P<0.001).
- The number of topical medications decreased significantly from a median of 3 to 2 (P<0.001), and 90% of patients remained free from repeat MPTSCPC at 12 months.
- Predictors of success included primary open-angle glaucoma diagnosis, prior glaucoma surgery, and concurrent procedures.
Conclusions:
- Micropulse transscleral cyclophotocoagulation (MPTSCPC) demonstrates favorable safety and efficacy in managing uncontrolled glaucoma, particularly primary open-angle glaucoma.
- The procedure leads to significant IOP reduction and decreased reliance on topical medications.
- MPTSCPC represents a valuable therapeutic option for glaucoma patients, with a high rate of sustained success up to 12 months.
More Related Videos
05:34A Mouse Model to Evaluate the Long-Term Structural and Functional Outcomes after the Reversal of Prolonged Unilateral Ureteric Obstruction
Published on: July 18, 2025
06:28Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients
Published on: June 24, 2019
Related Concept Videos
The Intermediate Value Theorem
Disassembly of Intermediate Filaments
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
Types of Intermediate Filaments
Formation of Intermediate Filaments
The Structure of Intermediate Filaments
Intermediate...
Predicting Reaction Outcomes